Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaBusinessDrug PoliticsHealthcare PoliticsSolutions Journalism
Psychedelic therapies?
Lancet May 19 2019 Psychedelic therapy
Posts in category Access to Affordable Medicines
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaDrug PoliticsHealthcare PoliticsSolutions Journalism
Canada’s expanding cannabis market sparks worries
Lancet Jan 12 2019 Canada’s expanding cannabis market
New Drugs for Psychosis & Schizophrenia
The Lancet May 5 2018 FDA Pimavanserin review
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaDrug PoliticsHealthcare PoliticsHealthcare Privatization: A Global Business CampaignSolutions Journalism
Canada considers solutions for fairer pharma prices
Ottawa is under pressure to do something bold. Spending by governments on patented drugs costing more than $10 000 per patient annually increased 60% last year, and spending on brand-name …
Medicine costs drive seniors to food banks
Over the past decade, the share of food bank users over age 65 increased from 3% to 7% in Toronto. Last year alone, there was a 27% jump in seniors …
Winner — 2017 Sanofi Pasteur Medal for Excellence in Health Research Journalism
Big Pharma Versus Everyone RoB Magazine November 2016
